Sign in
4

Changes in Ownership

Tarsus Pharmaceuticals, Inc. Filed Acc 0001827672-22-000002

Options or other derivatives

  • President and CEO acquired 199,264 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Azamian Bobak R. · President and CEO

Table II: Derivative

2 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2022-03-09 Grant or award : show line 1 in the form Stock Option (right to buy) +154,067 $19.59 2032-03-08 154,067 154,067 D
2022-03-09 Grant or award : show line 2 in the form Restricted Stock Units +45,197 45,197 45,197 D
Loading xslF345X03/wf-form4_164703352044513.xml…